Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 22607808)

1.

New generation QuIC assays for prion seeding activity.

Orrù CD, Wilham JM, Vascellari S, Hughson AG, Caughey B.

Prion. 2012 Apr-Jun;6(2):147-52. doi: 10.4161/pri.19430. Epub 2012 Apr 1. Review.

PMID:
22421206
2.

Candidate cell substrates, vaccine production, and transmissible spongiform encephalopathies.

Piccardo P, Cervenakova L, Vasilyeva I, Yakovleva O, Bacik I, Cervenak J, McKenzie C, Kurillova L, Gregori L, Pomeroy K, Asher DM.

Emerg Infect Dis. 2011 Dec;17(12):2262-9. doi: 10.3201/eid1712.110607.

3.

Comparison of nanofiltration efficacy in reducing infectivity of centrifuged versus ultracentrifuged 263K scrapie-infected brain homogenates in "spiked" albumin solutions.

Cardone F, Simoneau S, Arzel A, Puopolo M, Berardi VA, Abdel-Haq H, Galeno R, De Pascalis A, Sbriccoli M, Graziano S, Valanzano A, Porte P, Diringer H, Brown P, Flan B, Pocchiari M.

Transfusion. 2012 May;52(5):953-62. doi: 10.1111/j.1537-2995.2011.03425.x. Epub 2011 Nov 14.

PMID:
22082124
4.

Removal of prion infectivity by affinity ligand chromatography during OctaplasLG® manufacturing--results from animal bioassay studies.

Heger A, Bailey A, Neisser-Svae A, Ertl M, Römisch J, Svae TE.

Vox Sang. 2012 May;102(4):294-301. doi: 10.1111/j.1423-0410.2011.01563.x. Epub 2011 Nov 10.

PMID:
22070802
5.

Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977.

Abrams JY, Schonberger LB, Belay ED, Maddox RA, Leschek EW, Mills JL, Wysowski DK, Fradkin JE.

J Clin Endocrinol Metab. 2011 Oct;96(10):E1666-9. doi: 10.1210/jc.2011-1357. Epub 2011 Aug 3.

PMID:
21816775
6.

Prion disease blood test using immunoprecipitation and improved quaking-induced conversion.

Orrú CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, Caughey B.

MBio. 2011 May 10;2(3):e00078-11. doi: 10.1128/mBio.00078-11. Print 2011.

7.

Prospective 10-year surveillance of human prion diseases in Japan.

Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M.

Brain. 2010 Oct;133(10):3043-57. doi: 10.1093/brain/awq216. Epub 2010 Sep 20.

8.

Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.

Yamada M, Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Kitamoto T, Sato T, Nakamura Y, Mizusawa H.

Neuropathology. 2009 Oct;29(5):609-18. doi: 10.1111/j.1440-1789.2008.00987.x. Epub 2009 Jul 29.

PMID:
19659940
9.
10.

Risk behaviors in a rural community with a known point-source exposure to chronic wasting disease.

Garruto RM, Reiber C, Alfonso MP, Gastrich H, Needham K, Sunderman S, Walker S, Weeks J, Derosa N, Faisst E, Dunn J, Fanelli K, Shilkret K.

Environ Health. 2008 Jun 24;7:31. doi: 10.1186/1476-069X-7-31.

11.

Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features.

Furtner M, Gelpi E, Kiechl S, Knoflach M, Zangerl A, Gotwald T, Willeit J, Maier H, Ströbel T, Unterberger U, Budka H.

J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):229-31. doi: 10.1136/jnnp.2007.122267. No abstract available.

PMID:
18202218
12.

Prion inactivation using a new gaseous hydrogen peroxide sterilisation process.

Fichet G, Antloga K, Comoy E, Deslys JP, McDonnell G.

J Hosp Infect. 2007 Nov;67(3):278-86. Epub 2007 Oct 22.

PMID:
17942185
13.

Prion removal by nanofiltration under different experimental conditions.

Yunoki M, Tanaka H, Urayama T, Hattori S, Ohtani M, Ohkubo Y, Kawabata Y, Miyatake Y, Nanjo A, Iwao E, Morita M, Wilson E, MacLean C, Ikuta K.

Biologicals. 2008 Jan;36(1):27-36. Epub 2007 Sep 24.

PMID:
17890100
14.

Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.

Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, Sato T, Nakamura Y, Mizusawa H, Yamada M.

Neurology. 2007 Jul 24;69(4):360-7.

PMID:
17646628
15.

Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins.

Gregori L, Gurgel PV, Lathrop JT, Edwardson P, Lambert BC, Carbonell RG, Burton SJ, Hammond DJ, Rohwer RG.

Lancet. 2006 Dec 23;368(9554):2226-30.

PMID:
17189034
16.

Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.

Brown P, Brandel JP, Preece M, Sato T.

Neurology. 2006 Aug 8;67(3):389-93. Epub 2006 Jul 19. Erratum in: Neurology. 2006 Oct 24;67(8):1528. Preese, Michael [corrected to Preece, Michael].

PMID:
16855204
17.

Increased asymmetric pulvinar magnetic resonance imaging signals in Creutzfeldt-Jakob disease with florid plaques following a cadaveric dura mater graft.

Wakisaka Y, Santa N, Doh-ura K, Kitamoto T, Ibayashi S, Iida M, Iwaki T.

Neuropathology. 2006 Feb;26(1):82-8.

PMID:
16521484
18.

Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.

Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, Klug GM, Sutcliffe T, Giulivi A, Alperovitch A, Delasnerie-Laupretre N, Brandel JP, Poser S, Kretzschmar H, Rietveld I, Mitrova E, Cuesta Jde P, Martinez-Martin P, Glatzel M, Aguzzi A, Knight R, Ward H, Pocchiari M, van Duijn CM, Will RG, Zerr I.

Neurology. 2005 May 10;64(9):1586-91.

PMID:
15883321
19.

Novel methods for disinfection of prion-contaminated medical devices.

Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A, McDonnell G, Brown P, Lasmézas CI, Deslys JP.

Lancet. 2004 Aug 7-13;364(9433):521-6.

PMID:
15302195
20.

The normal population distribution of PRNP codon 129 polymorphism.

Nurmi MH, Bishop M, Strain L, Brett F, McGuigan C, Hutchison M, Farrell M, Tilvis R, Erkkilä S, Simell O, Knight R, Haltia M.

Acta Neurol Scand. 2003 Nov;108(5):374-8.

PMID:
14616310
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk